Does the media prefer IBT or WWH?

In the previous week, Worldwide Healthcare had 6 more articles in the media than International Biotechnology. MarketBeat recorded 8 mentions for Worldwide Healthcare and 2 mentions for International Biotechnology. Worldwide Healthcare's average media sentiment score of 1.84 beat International Biotechnology's score of 0.34 indicating that Worldwide Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment International Biotechnology 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Worldwide Healthcare 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts recommend ASHM or IBT?

Ashmore Group presently has a consensus price target of GBX 155, indicating a potential downside of 27.02%. Given Ashmore Group's stronger consensus rating and higher possible upside, research analysts plainly believe Ashmore Group is more favorable than International Biotechnology. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ashmore Group 2 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.67 International Biotechnology 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Does the media refer more to ASHM or IBT?

In the previous week, Ashmore Group and Ashmore Group both had 2 articles in the media. Ashmore Group's average media sentiment score of 0.47 beat International Biotechnology's score of 0.34 indicating that Ashmore Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ashmore Group 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral International Biotechnology 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

International Biotechnology (IBT) Competitors

GBX 1,096 -19.00 (-1.70%)

As of 05:13 AM Eastern

Compare

IBT vs. SNN, WWH, FSV, ASHM, and BNKR

Should you buy International Biotechnology stock or one of its competitors? MarketBeat compares International Biotechnology with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with International Biotechnology include Sanne Group (SNN), Worldwide Healthcare (WWH), Fidelity Investment Trust - Fidelity Special Values (FSV), Ashmore Group (ASHM), and The Bankers Investment Trust (BNKR). These companies are all part of the "asset management" industry.

How does International Biotechnology compare to Sanne Group?

International Biotechnology (LON:IBT) and Sanne Group (LON:SNN) are both small-cap asset management industry companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, earnings, valuation, risk and media sentiment.

International Biotechnology has a net margin of 82.27% compared to Sanne Group's net margin of 0.00%. International Biotechnology's return on equity of 27.35% beat Sanne Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
International Biotechnology	82.27%	27.35%	3.57%
Sanne Group	N/A	N/A	N/A

6.7% of International Biotechnology shares are held by institutional investors. 1.1% of International Biotechnology shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

International Biotechnology pays an annual dividend of GBX 31.81 per share and has a dividend yield of 2.9%. Sanne Group pays an annual dividend of GBX 0.10 per share. International Biotechnology pays out 13.2% of its earnings in the form of a dividend. Sanne Group pays out -2.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

International Biotechnology has higher earnings, but lower revenue than Sanne Group. Sanne Group is trading at a lower price-to-earnings ratio than International Biotechnology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
International Biotechnology	£78.01M	4.47	£37.91M	£241.73	4.53
Sanne Group	£194.16M	0.00	N/A	-£4.50	N/A

In the previous week, International Biotechnology had 2 more articles in the media than Sanne Group. MarketBeat recorded 2 mentions for International Biotechnology and 0 mentions for Sanne Group. International Biotechnology's average media sentiment score of 0.34 beat Sanne Group's score of 0.00 indicating that International Biotechnology is being referred to more favorably in the media.

Company	Overall Sentiment
International Biotechnology	Neutral
Sanne Group	Neutral

Summary

International Biotechnology beats Sanne Group on 10 of the 12 factors compared between the two stocks.

How does International Biotechnology compare to Worldwide Healthcare?

International Biotechnology (LON:IBT) and Worldwide Healthcare (LON:WWH) are both small-cap financial services companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, earnings, risk, valuation and dividends.

International Biotechnology pays an annual dividend of GBX 31.81 per share and has a dividend yield of 2.9%. Worldwide Healthcare pays an annual dividend of GBX 2.40 per share and has a dividend yield of 0.6%. International Biotechnology pays out 13.2% of its earnings in the form of a dividend. Worldwide Healthcare pays out 9.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

6.7% of International Biotechnology shares are owned by institutional investors. Comparatively, 8.0% of Worldwide Healthcare shares are owned by institutional investors. 1.1% of International Biotechnology shares are owned by company insiders. Comparatively, 0.2% of Worldwide Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Worldwide Healthcare has higher revenue and earnings than International Biotechnology. International Biotechnology is trading at a lower price-to-earnings ratio than Worldwide Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
International Biotechnology	£78.01M	4.47	£37.91M	£241.73	4.53
Worldwide Healthcare	£118.16M	11.61	£227.88M	£26.70	14.30

In the previous week, Worldwide Healthcare had 6 more articles in the media than International Biotechnology. MarketBeat recorded 8 mentions for Worldwide Healthcare and 2 mentions for International Biotechnology. Worldwide Healthcare's average media sentiment score of 1.84 beat International Biotechnology's score of 0.34 indicating that Worldwide Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
International Biotechnology	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Worldwide Healthcare	7 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

International Biotechnology has a beta of 0.321, indicating that its share price is 68% less volatile than the broader market. Comparatively, Worldwide Healthcare has a beta of 0.5198687, indicating that its share price is 48% less volatile than the broader market.

Worldwide Healthcare has a net margin of 85.46% compared to International Biotechnology's net margin of 82.27%. International Biotechnology's return on equity of 27.35% beat Worldwide Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
International Biotechnology	82.27%	27.35%	3.57%
Worldwide Healthcare	85.46%	8.01%	-2.02%

Summary

Worldwide Healthcare beats International Biotechnology on 10 of the 15 factors compared between the two stocks.

How does International Biotechnology compare to Fidelity Investment Trust - Fidelity Special Values?

International Biotechnology (LON:IBT) and Fidelity Investment Trust - Fidelity Special Values (LON:FSV) are both small-cap financial services companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk.

Fidelity Investment Trust - Fidelity Special Values has higher revenue and earnings than International Biotechnology. Fidelity Investment Trust - Fidelity Special Values is trading at a lower price-to-earnings ratio than International Biotechnology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
International Biotechnology	£78.01M	4.47	£37.91M	£241.73	4.53
Fidelity Investment Trust - Fidelity Special Values	£354.63M	4.06	£223.72M	£109.34	4.06

International Biotechnology pays an annual dividend of GBX 31.81 per share and has a dividend yield of 2.9%. Fidelity Investment Trust - Fidelity Special Values pays an annual dividend of GBX 10.20 per share and has a dividend yield of 2.3%. International Biotechnology pays out 13.2% of its earnings in the form of a dividend. Fidelity Investment Trust - Fidelity Special Values pays out 9.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

International Biotechnology has a beta of 0.321, suggesting that its stock price is 68% less volatile than the broader market. Comparatively, Fidelity Investment Trust - Fidelity Special Values has a beta of 1.2700156, suggesting that its stock price is 27% more volatile than the broader market.

6.7% of International Biotechnology shares are owned by institutional investors. Comparatively, 12.2% of Fidelity Investment Trust - Fidelity Special Values shares are owned by institutional investors. 1.1% of International Biotechnology shares are owned by insiders. Comparatively, 0.2% of Fidelity Investment Trust - Fidelity Special Values shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, International Biotechnology had 1 more articles in the media than Fidelity Investment Trust - Fidelity Special Values. MarketBeat recorded 2 mentions for International Biotechnology and 1 mentions for Fidelity Investment Trust - Fidelity Special Values. Fidelity Investment Trust - Fidelity Special Values' average media sentiment score of 1.69 beat International Biotechnology's score of 0.34 indicating that Fidelity Investment Trust - Fidelity Special Values is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
International Biotechnology	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Fidelity Investment Trust - Fidelity Special Values	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Fidelity Investment Trust - Fidelity Special Values has a net margin of 95.92% compared to International Biotechnology's net margin of 82.27%. International Biotechnology's return on equity of 27.35% beat Fidelity Investment Trust - Fidelity Special Values' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
International Biotechnology	82.27%	27.35%	3.57%
Fidelity Investment Trust - Fidelity Special Values	95.92%	25.87%	0.33%

Summary

International Biotechnology beats Fidelity Investment Trust - Fidelity Special Values on 8 of the 15 factors compared between the two stocks.

How does International Biotechnology compare to Ashmore Group?

Ashmore Group (LON:ASHM) and International Biotechnology (LON:IBT) are both small-cap financial services companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, institutional ownership, valuation, risk, analyst recommendations and earnings.

In the previous week, Ashmore Group and Ashmore Group both had 2 articles in the media. Ashmore Group's average media sentiment score of 0.47 beat International Biotechnology's score of 0.34 indicating that Ashmore Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ashmore Group	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
International Biotechnology	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

40.4% of Ashmore Group shares are owned by institutional investors. Comparatively, 6.7% of International Biotechnology shares are owned by institutional investors. 37.5% of Ashmore Group shares are owned by insiders. Comparatively, 1.1% of International Biotechnology shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

International Biotechnology has a net margin of 82.27% compared to Ashmore Group's net margin of 78.55%. International Biotechnology's return on equity of 27.35% beat Ashmore Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ashmore Group	78.55%	14.60%	4.52%
International Biotechnology	82.27%	27.35%	3.57%

Ashmore Group has a beta of 0.962, meaning that its stock price is 4% less volatile than the broader market. Comparatively, International Biotechnology has a beta of 0.321, meaning that its stock price is 68% less volatile than the broader market.

Ashmore Group pays an annual dividend of GBX 16.90 per share and has a dividend yield of 8.0%. International Biotechnology pays an annual dividend of GBX 31.81 per share and has a dividend yield of 2.9%. Ashmore Group pays out 102.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. International Biotechnology pays out 13.2% of its earnings in the form of a dividend.

Ashmore Group has higher revenue and earnings than International Biotechnology. International Biotechnology is trading at a lower price-to-earnings ratio than Ashmore Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ashmore Group	£135.90M	10.16	£94.67M	£16.54	12.84
International Biotechnology	£78.01M	4.47	£37.91M	£241.73	4.53

Ashmore Group presently has a consensus price target of GBX 155, indicating a potential downside of 27.02%. Given Ashmore Group's stronger consensus rating and higher possible upside, research analysts plainly believe Ashmore Group is more favorable than International Biotechnology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ashmore Group	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67
International Biotechnology	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Ashmore Group beats International Biotechnology on 13 of the 17 factors compared between the two stocks.

How does International Biotechnology compare to The Bankers Investment Trust?

International Biotechnology (LON:IBT) and The Bankers Investment Trust (LON:BNKR) are both small-cap financial services companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, media sentiment, profitability, dividends, valuation, institutional ownership and earnings.

6.7% of International Biotechnology shares are owned by institutional investors. Comparatively, 0.5% of The Bankers Investment Trust shares are owned by institutional investors. 1.1% of International Biotechnology shares are owned by company insiders. Comparatively, 0.0% of The Bankers Investment Trust shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

International Biotechnology pays an annual dividend of GBX 31.81 per share and has a dividend yield of 2.9%. The Bankers Investment Trust pays an annual dividend of GBX 2.77 per share and has a dividend yield of 1.9%. International Biotechnology pays out 13.2% of its earnings in the form of a dividend. The Bankers Investment Trust pays out 9.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

In the previous week, International Biotechnology had 2 more articles in the media than The Bankers Investment Trust. MarketBeat recorded 2 mentions for International Biotechnology and 0 mentions for The Bankers Investment Trust. International Biotechnology's average media sentiment score of 0.34 beat The Bankers Investment Trust's score of 0.00 indicating that International Biotechnology is being referred to more favorably in the media.

Company	Overall Sentiment
International Biotechnology	Neutral
The Bankers Investment Trust	Neutral

International Biotechnology has a beta of 0.321, indicating that its share price is 68% less volatile than the broader market. Comparatively, The Bankers Investment Trust has a beta of 0.618, indicating that its share price is 38% less volatile than the broader market.

The Bankers Investment Trust has a net margin of 1,132.30% compared to International Biotechnology's net margin of 82.27%. International Biotechnology's return on equity of 27.35% beat The Bankers Investment Trust's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
International Biotechnology	82.27%	27.35%	3.57%
The Bankers Investment Trust	1,132.30%	22.55%	6.13%

The Bankers Investment Trust has higher revenue and earnings than International Biotechnology. International Biotechnology is trading at a lower price-to-earnings ratio than The Bankers Investment Trust, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
International Biotechnology	£78.01M	4.47	£37.91M	£241.73	4.53
The Bankers Investment Trust	£322.40M	4.19	£218.53M	£30.13	4.86

Summary

International Biotechnology beats The Bankers Investment Trust on 8 of the 15 factors compared between the two stocks.

Get International Biotechnology News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IBT vs. The Competition

Export

Metric	International Biotechnology	Asset Management Industry	Financial Sector	LON Exchange
Market Cap	£348.84M	£2.49B	£6.21B	£2.78B
Dividend Yield	2.78%	6.00%	5.24%	6.12%
P/E Ratio	4.53	62.73	29.67	368.15
Price / Sales	4.47	1,838.81	1,175.13	84,703.07
Price / Cash	155.74	60.50	117.40	27.89
Price / Book	1.43	1.32	6.56	7.50
Net Income	£37.91M	£265.96M	£1.13B	£5.89B
7 Day Performance	-3.01%	-0.40%	-0.19%	0.05%
1 Month Performance	12.99%	-0.09%	0.14%	-1.30%
1 Year Performance	67.07%	7.26%	15.07%	62.22%

International Biotechnology Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IBT International Biotechnology	N/A	GBX 1,096 -1.7%	N/A	+74.2%	£348.84M	£78.01M	4.53	N/A	News Coverage
SNN Sanne Group	N/A	N/A	N/A	N/A	£1.50B	£194.16M	N/A	20,100
WWH Worldwide Healthcare	N/A	GBX 390.56 -1.0%	N/A	+25.2%	£1.42B	£118.16M	14.63	N/A	Positive News Insider Trade
FSV Fidelity Investment Trust - Fidelity Special Values	N/A	GBX 434.50 +0.8%	N/A	+21.0%	£1.41B	£354.63M	3.97	25,000
ASHM Ashmore Group	1.2479 of 5 stars	GBX 213.41 -0.6%	GBX 155 -27.4%	+26.7%	£1.40B	£135.90M	12.90	283

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:IBT) was last updated on 7/17/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

International Biotechnology (IBT) Competitors

IBT vs. SNN, WWH, FSV, ASHM, and BNKR

How does International Biotechnology compare to Sanne Group?

Summary

How does International Biotechnology compare to Worldwide Healthcare?

Summary

How does International Biotechnology compare to Fidelity Investment Trust - Fidelity Special Values?

Summary

How does International Biotechnology compare to Ashmore Group?

Summary

How does International Biotechnology compare to The Bankers Investment Trust?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IBT vs. The Competition

International Biotechnology Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

International Biotechnology (IBT) Competitors

IBT vs. SNN, WWH, FSV, ASHM, and BNKR

How does International Biotechnology compare to Sanne Group?

Is IBT or SNN more profitable?

Do institutionals & insiders have more ownership in IBT or SNN?

Is IBT or SNN a better dividend stock?

Which has better valuation & earnings, IBT or SNN?

Does the media prefer IBT or SNN?

Summary

How does International Biotechnology compare to Worldwide Healthcare?

Is IBT or WWH a better dividend stock?

Do institutionals & insiders have more ownership in IBT or WWH?

Which has stronger valuation and earnings, IBT or WWH?

Does the media prefer IBT or WWH?

Which has more risk & volatility, IBT or WWH?

Is IBT or WWH more profitable?

Summary

How does International Biotechnology compare to Fidelity Investment Trust - Fidelity Special Values?

Which has higher earnings & valuation, IBT or FSV?

Is IBT or FSV a better dividend stock?

Which has more risk & volatility, IBT or FSV?

Do institutionals & insiders believe in IBT or FSV?

Does the media prefer IBT or FSV?

Is IBT or FSV more profitable?

Summary

How does International Biotechnology compare to Ashmore Group?

Does the media refer more to ASHM or IBT?

Do institutionals and insiders believe in ASHM or IBT?

Is ASHM or IBT more profitable?

Which has more risk and volatility, ASHM or IBT?

Is ASHM or IBT a better dividend stock?

Which has better valuation & earnings, ASHM or IBT?

Do analysts recommend ASHM or IBT?

Summary

How does International Biotechnology compare to The Bankers Investment Trust?

Do insiders and institutionals have more ownership in IBT or BNKR?

Is IBT or BNKR a better dividend stock?

Does the media refer more to IBT or BNKR?

Which has more risk and volatility, IBT or BNKR?

Is IBT or BNKR more profitable?

Which has better earnings and valuation, IBT or BNKR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IBT vs. The Competition

International Biotechnology Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools